Eudald Casals
Overview
Explore the profile of Eudald Casals including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casals E, Li S, Jia Z, Casals G, Zeng M
Front Mol Biosci
. 2024 Apr;
11:1399695.
PMID: 38590454
No abstract available.
2.
Tang J, Zhang Y, Liu X, Lin Y, Liang L, Li X, et al.
Adv Healthc Mater
. 2024 Jan;
13(12):e2304156.
PMID: 38271691
Despite considerable interest in medical and pharmaceutical fields, there remains a notable absence of functional textiles that concurrently exhibit antibacterial and antioxidant properties. Herein, a new composite fabric constructed using...
3.
Zhang Y, Ju S, Casals G, Tang J, Lin Y, Li X, et al.
RSC Adv
. 2023 Nov;
13(47):33187-33203.
PMID: 37954413
Advanced oxidation processes using TiO-based nanomaterials are sustainable technologies that hold great promise for the degradation of many types of pollutants including pharmaceutical residues. A wide variety of heterostructures coupling...
4.
Zeng M, Zhang X, Tang J, Liu X, Lin Y, Guo D, et al.
Nanoscale
. 2023 Aug;
15(35):14365-14379.
PMID: 37609757
Cerium oxide nanozymes (CeONZs) are attracting vast attention due to their antioxidant and catalytic properties and mimic the activities of multiple endogenous enzymes. However, as is the case for nanomedicines...
5.
Garcia A, Camara J, Boullosa A, Gusta M, Mondragon L, Schwartz Jr S, et al.
Nanomaterials (Basel)
. 2023 Aug;
13(15).
PMID: 37570527
Cerium oxide nanoparticles (CeONPs) have exceptional catalytic properties, rendering them highly effective in removing excessive reactive oxygen species (ROS) from biological environments, which is crucial in safeguarding these environments against...
6.
Ernst L, Mondragon L, Ramis J, Gusta M, Yudina T, Casals E, et al.
Antioxidants (Basel)
. 2023 Mar;
12(3).
PMID: 36979013
Nanoparticle (NP) pharmacokinetics significantly differ from traditional small molecule principles. From this emerges the need to create new tools and concepts to harness their full potential and avoid unnecessary risks....
7.
Badia A, Duarri A, Salas A, Rosell J, Ramis J, Gusta M, et al.
ACS Nano
. 2023 Jan;
PMID: 36596252
Increased oxidative stress in the retina and retinal pigment epithelium is implicated in age-related macular degeneration (AMD). Antioxidant cerium oxide nanoparticles (CeONPs) have been used to treat degenerative retinal pathologies...
8.
Zeng M, Guo D, Fernandez-Varo G, Zhang X, Fu S, Ju S, et al.
Mol Pharm
. 2022 Dec;
20(2):886-904.
PMID: 36563052
The integration of progressive technologies such as nanomedicine with the use of natural products from traditional medicine (TM) provides a unique opportunity for the longed-for harmonization between traditional and modern...
9.
Liu Y, Wang X, Li X, Qiao S, Huang G, Hermann D, et al.
ACS Appl Mater Interfaces
. 2022 Sep;
14(38):44015.
PMID: 36121770
No abstract available.
10.
Rodriguez-Garcia M, Fernandez-Varo G, Hidalgo S, Rodriguez G, Martinez I, Zeng M, et al.
Molecules
. 2022 Mar;
27(6).
PMID: 35335253
Circulating levels of 2-hydroxybutyrate (2HB) are highly related to glycemic status in different metabolomic studies. According to recent evidence, 2HB is an early biomarker of the future development of dysglycemia...